711 related articles for article (PubMed ID: 11456468)
1. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
Labrie F; Luu-The V; Labrie C; Simard J
Front Neuroendocrinol; 2001 Jul; 22(3):185-212. PubMed ID: 11456468
[TBL] [Abstract][Full Text] [Related]
2. Is dehydroepiandrosterone a hormone?
Labrie F; Luu-The V; Bélanger A; Lin SX; Simard J; Pelletier G; Labrie C
J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
[TBL] [Abstract][Full Text] [Related]
3. DHEA, important source of sex steroids in men and even more in women.
Labrie F
Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
[TBL] [Abstract][Full Text] [Related]
4. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
Labrie F
J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
[TBL] [Abstract][Full Text] [Related]
5. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.
Labrie F; Luu-The V; Labrie C; Bélanger A; Simard J; Lin SX; Pelletier G
Endocr Rev; 2003 Apr; 24(2):152-82. PubMed ID: 12700178
[TBL] [Abstract][Full Text] [Related]
6. Adrenal androgens and intracrinology.
Labrie F
Semin Reprod Med; 2004 Nov; 22(4):299-309. PubMed ID: 15635498
[TBL] [Abstract][Full Text] [Related]
7. DHEA and intracrinology at menopause, a positive choice for evolution of the human species.
Labrie F; Labrie C
Climacteric; 2013 Apr; 16(2):205-13. PubMed ID: 23126249
[TBL] [Abstract][Full Text] [Related]
8. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.
Labrie F; Bélanger A; Luu-The V; Labrie C; Simard J; Cusan L; Gomez JL; Candas B
Steroids; 1998; 63(5-6):322-8. PubMed ID: 9618795
[TBL] [Abstract][Full Text] [Related]
9. Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA.
Labrie F
Endocr Relat Cancer; 2006 Jun; 13(2):335-55. PubMed ID: 16728567
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
[TBL] [Abstract][Full Text] [Related]
11. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
12. Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
Abraham GE; Maroulis GB
Obstet Gynecol; 1975 Mar; 45(3):271-4. PubMed ID: 163457
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone, androgens and the mammary gland.
Labrie F
Gynecol Endocrinol; 2006 Mar; 22(3):118-30. PubMed ID: 16835073
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
15. [Intracrinology and dehydroepiandrosterone--a new perspective for the use of androgens in hormone replacement therapy in postmenopausal women].
Perzyło K; Kulik-Rechberger B; Gałczyński K; Rechberger T
Ginekol Pol; 2011 Sep; 82(9):690-5. PubMed ID: 22379930
[TBL] [Abstract][Full Text] [Related]
16. Science of intracrinology in postmenopausal women.
Labrie F; Bélanger A; Pelletier G; Martel C; Archer DF; Utian WH
Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
[TBL] [Abstract][Full Text] [Related]
17. Intracrinology and the skin.
Labrie F; Luu-The V; Labrie C; Pelletier G; El-Alfy M
Horm Res; 2000; 54(5-6):218-29. PubMed ID: 11595810
[TBL] [Abstract][Full Text] [Related]
18. Extragonadal synthesis of sex steroids: intracrinology.
Labrie F
Ann Endocrinol (Paris); 2003 Apr; 64(2):95-107. PubMed ID: 12773942
[TBL] [Abstract][Full Text] [Related]
19. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
Samojlik E; Veldhuis JD; Wells SA; Santen RJ
J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
[TBL] [Abstract][Full Text] [Related]
20. Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues.
Labrie F
Menopause; 2019 Feb; 26(2):220-224. PubMed ID: 30130283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
